US Stock Movers | Boston Scientific rises 3% pre-market as restructuring plan boosts confidence and Q2 earnings report due tomorrow

```htmlGolden Ten Data July 29｜Medical device manufacturer Boston Scientific (BSX.US) rose about 3% in pre-market trading. According to reports, the company will announce its second quarter financial report before the U.S. market opens on July 29 (Wednesday). Last quarter, the company delivered better-than-expected results (revenue of $5.2 billion, up 11.6% year-on-year), but revenue guidance fell short of expectations and a downward adjustment of full-year EPS once put pressure on the stock price. The market is paying attention to whether this financial report can reverse the situation. On July 27, the company announced its 2026 restructuring plan— the board of directors approved a total expenditure of $70-80 million, with an expected annual cost savings of about $500 million by 2029, part of which will be reinvested in growth plans. This move is interpreted by the market as a signal of proactive management.```